These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27223667)

  • 21. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
    Coric V; Taskiran S; Pittenger C; Wasylink S; Mathalon DH; Valentine G; Saksa J; Wu YT; Gueorguieva R; Sanacora G; Malison RT; Krystal JH
    Biol Psychiatry; 2005 Sep; 58(5):424-8. PubMed ID: 15993857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation.
    Misri S; Milis L
    J Clin Psychopharmacol; 2004 Dec; 24(6):624-7. PubMed ID: 15538124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive compulsive disorder and the efficacy of qEEG-guided neurofeedback treatment: a case series.
    Sürmeli T; Ertem A
    Clin EEG Neurosci; 2011 Jul; 42(3):195-201. PubMed ID: 21870473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study.
    Sarris J; Byrne GJ; Oliver G; Cribb L; Blair-West S; Castle D; Dean OM; Camfield DA; Brakoulias V; Bousman C; Dowling N; Ee C; Murphy J; Menon R; Berk M; Chamoli S; Boschen M; Ng CH
    CNS Spectr; 2022 Oct; 27(5):588-597. PubMed ID: 34165060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.
    Alves-Pereira R; Fontes M; Cordeiro V; Bandeira ID; Faria-Guimarães D; Silva SS; Mello RP; Leal GC; Sampaio AS; Quarantini LC
    Clin Neuropharmacol; 2024 Jan-Feb 01; 47(1):17-21. PubMed ID: 38194244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder.
    Vakili Y; Gharaee B; Habibi M
    Iran J Psychiatry Behav Sci; 2015 Jun; 9(2):e845. PubMed ID: 26288647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil in treatment-resistant bipolar disorder.
    Burt T; Sachs GS; Demopulos C
    Biol Psychiatry; 1999 Apr; 45(8):959-64. PubMed ID: 10386177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
    Tosto G; Talarico G; Lenzi GL; Bruno G
    Neurol Sci; 2008 Sep; 29(4):269-70. PubMed ID: 18810603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.
    Delle Chiaie R; Scarciglia P; Pasquini M; Caredda M; Biondi M
    Clin Pract Epidemiol Ment Health; 2011; 7():107-11. PubMed ID: 21686322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia.
    Hussain A; Dar MA; Wani RA; Shah MS; Jan MM; Malik YA; Chandel RK; Margoob MA
    Indian J Psychol Med; 2015; 37(2):154-8. PubMed ID: 25969599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence.
    Couto JP; Moreira R
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():245-254. PubMed ID: 29908912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder.
    Hankin CS; Koran LM; Bronstone A; Black DW; Sheehan DV; Hollander E; Dunn JD; Culpepper L; Knispel J; Dougherty DD; Wang Z
    CNS Spectr; 2009 Dec; 14(12):695-703. PubMed ID: 20394177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
    Pittenger C; Krystal JH; Coric V
    NeuroRx; 2006 Jan; 3(1):69-81. PubMed ID: 16490414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Therapeutic Effect of Electroconvulsive Therapy in Patients With Obsessive-compulsive Disorder: A Quasi-experimental Study.
    Noorazar SG; Emamizad S; Fakhari-Dehkharghani A; Pouya P
    Basic Clin Neurosci; 2023; 14(1):19-30. PubMed ID: 37346874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yoga therapy for Obsessive Compulsive Disorder (OCD): A case series from India.
    Bhat SGS; Arasappa R; Jagannathan A; Varambally S
    Asian J Psychiatr; 2021 Aug; 62():102739. PubMed ID: 34243060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.
    Odlaug BL; Weinhandl E; Mancebo MC; Mortensen EL; Eisen JL; Rasmussen SA; Schreiber LR; Grant JE
    Ann Clin Psychiatry; 2014 Feb; 26(1):39-46. PubMed ID: 24501729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obsessive-compulsive disorder induced by donepezil in a patient with Alzheimer's disease.
    Echizen K; Hirose D
    PCN Rep; 2024 Jun; 3(2):e217. PubMed ID: 38887312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in both severe obsessive-compulsive disorder and refractory tardive dystonia following electroconvulsive therapy: A case report.
    Mihara Y; Otsuki K; Hayashi M; Yamashita S; Nagahama M; Hayashida M; Wake R; Hashioka S; Abe S; Inagaki M
    PCN Rep; 2022 Jun; 1(2):e15. PubMed ID: 38868639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for a Pragmatic Trial of Pharmacotherapy Options Following Unsatisfactory Initial Treatment in OCD (PROCEED).
    Wang P; Gu W; Gao J; Wang C; Fang J; Hu M; Xiang H; Li B; Liu N; Tang W; Wang X; Jia Y; Li Y; Cheng Y; Tang Z; Simpson HB; Stein DJ; Wang Z
    Front Psychiatry; 2022; 13():822976. PubMed ID: 35651818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trazodone Augmentation in OCD: A Case Series Report.
    Marazziti D; Gemignani A; Dell'osso L
    CNS Spectr; 1999 Dec; 4(12):48-9. PubMed ID: 18311107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.